Display options
Share it on

Ann Hematol. 2020 Mar;99(3):675. doi: 10.1007/s00277-020-03933-7.

Correction to: Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus.

Annals of hematology

Pau Montesinos, Juan Bergua, Joana Infante, Jordi Esteve, José Eduardo Guimaraes, Jordi Sierra, Miguel Ángel Sanz

Affiliations

  1. Hematology Department, Hospital Universitari I Politècnic La Fe, Av, Fernando Abril Martorell, 106, 46026, Valencia, Spain. [email protected].
  2. CIBERONC Instituto de Salud Carlos III, Madrid, Spain. [email protected].
  3. Division of Hematology/Oncology, Hospital San Pedro Alcántara, Cáceres, Spain.
  4. Serviço de Hematologia e Transplantação deMedula Óssea, Hospital de SantaMaria, Centro Hospitalar de Lisboa Norte, Lisbon, Portugal.
  5. Department of Hematology, IDIBAPS Hospital Clinic, Barcelona, Spain.
  6. Serviço de Hematologia Clínica, Centro Hospitalar Universitário de São João, Porto, Portugal.
  7. Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau and Jose Carreras Leukemia Research Institutes, Autonomous University of Barcelona, Barcelona, Spain.
  8. Hematology Department, Hospital Universitari I Politècnic La Fe, Av, Fernando Abril Martorell, 106, 46026, Valencia, Spain.

PMID: 32002657 DOI: 10.1007/s00277-020-03933-7

Abstract

After publication of this paper, the authors determined that an additional information in the funding section was missing.

Publication Types